Company / Revenue per Share
IONIS PHARMACEUTICALS INC Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$5.98
FY2025
5-year range
$1.08 / $5.98
FY2021-FY2025
Trend
+280.7%
vs FY2024
Sector context
#61 of 154
Health Care
What the data says
Revenue per Share changed +281% YoY in FY2025, a notable deviation from the 9-year average annual change of +53%.
Based on SEC 10-K filings.
5.98 in FY2025 with a 5-year CAGR of +23.6%.
Improved from $2.28 to $5.98 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +77.1%
- 5-Year CAGR
- +23.6%
- 10-Year CAGR
- -
Sector benchmark
#61 of 154 in Health CareTop 40% of 154This company $5.98 Sector average $10.35
▼
-42.3% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 280.7% year-over-year.
- Ranks #61 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.98 | +280.7% |
| FY2024 | $1.57 | -31.3% |
| FY2023 | $2.28 | +112.4% |
| FY2022 | $1.08 | -65.7% |
| FY2021 | $3.13 | +51.6% |
| FY2020 | $2.07 | -42.2% |
| FY2019 | $3.58 | +209.7% |
| FY2018 | $1.16 | +27.4% |
| FY2017 | $0.91 | -68.5% |
| FY2016 | $2.88 | +20.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026